设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编兼编辑部主任:
杨秋

邮发代号:80-528
定价:20.00元
全年:240.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2022 年第 9 期 第 17 卷

如何提高退行性二尖瓣病变二尖瓣成形术的疗效

How to improve the effect of mitral valvuloplasty on degenerative mitral valve disease

作者:仲肇基刘盛

英文作者:Zhong Zhaoji Liu Sheng

单位:中国医学科学院北京协和医学院国家心血管病中心阜外医院成人心脏外科中心,北京100037

英文单位:Adult Cardiac Surgery Center Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100037 China

关键词:

英文关键词:

  • 摘要:
  • 随着经济的发展及人口老龄化进程加快,老年性疾病发病率有上升趋势。退行性二尖瓣反流是西方国家最常见的瓣膜病,在中国也在不断发展。退行性二尖瓣病变将逐步成为我国二尖瓣病变的首要原因,而二尖瓣成形术(也称瓣膜修复术)是治疗退行性二尖瓣关闭不全的首选方法。如何借鉴国外经验,结合我国特点,建立适合我国的诊疗策略,是提高我国二尖瓣病变诊治水平的关键。本文从提高退行性二尖瓣病变术前诊断准确率、分层评估筛选患者与建立转诊治疗体系、制定精准成形策略与提高成形成功率和远期效果等多个方面结合相关研究成果进行简要论述,以期在保障成像效果的基础上扭转临床医师及患者瓣膜置换的惯性思维,促进二尖瓣成形术的广泛应用。

  • With the development of economy and the acceleration of population aging process, the incidence of senile diseases has an upward trend. Degenerative mitral regurgitation is the most common valvular disease in the West and is growing in China. Degenerative mitral valve disease will gradually become the primary cause of mitral valve disease in China, and mitral valvuloplasty (valve repair) is the first choice for the treatment of degenerative mitral insufficiency. It is the key to improve the diagnosis and treatment of mitral valve disease in China on how to learn from foreign experience and combine the characteristics of our country to establish a diagnosis and treatment strategy suitable for our country. This paper briefly discusses from the aspects of improving the accuracy of preoperative diagnosis of degenerative mitral valve disease, hierarchical evaluation and screening of patients and the establishment of referral treatment system, formulating accurate shaping strategy and improving the success rate and long-term effect of shaping, with a view to reversing the inertial thinking of clinicians and patients on valve replacement on the basis of ensuring the imaging effect, and promoting the wide application of mitral valve plasty.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:010-60213898
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭